Turn incomplete claims intoa complete market.

Patient-data enrichment for claims & EHR — one dull stream split into the full spectrum, so every model and every rep decision sees the whole market.

Prism · Patient visibility

Addressable market, recovered

Claims only18%
With Prism46%
ESR1+ biomarker61%
HR+ biomarker90%
+28pp averagevisibility lift

Turn the 90% of your market that claims can't see into a precision targeting asset.

Features

Inside Prism

Biomarker Inference

Sees What Claims Miss

  • Infers biomarker status from claims patterns
  • Restores lines of therapy
  • Rebuilds missing journey events
  • Sizes the true eligible population
One Patient View

Unifies Your Whole Data Estate

  • Joins claims, CRM and EHR
  • Resolves patient identity across sources
  • De-identifies at ingestion
  • Preserves lineage end to end
Eligibility Prediction

Finds Patients Before Claims Do

  • Flags eligible patients weeks early
  • Predicts the pathway they arrive through
  • Validated against real-world outcomes
  • Feeds targeting and call plans directly
Built forBrand directorsCommercial analyticsData scienceField planning
In production
+28ppaverage patient visibility
30×ESR1+ biomarker visibility
80%of eligible patients found early
60%NPS lift on targeted physicians

All metrics from production deployments, per Akaike Technologies. Field impact independently measured against matched controls by Definitive Healthcare where noted. Detailed case studies available under NDA.

Related
SOC 2 Type II audited (Akaike)
Evaluation on every model run
Claim-level audit trails
Your cloud or ours

The future of pharma GTM
starts with intent.

Book a walkthrough